KURA
Income statement / Annual
Last year (2023), Kura Oncology, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Kura Oncology, Inc.'s net income was -$152.63 M.
See Kura Oncology, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$849,000.00 |
$759,000.00 |
$558,000.00 |
$194,000.00 |
$0.00 |
$10,000.00 |
$30,000.00 |
$31,000.00 |
$20,000.00 |
$23,907.00 |
| Gross Profit |
-$849,000.00 |
-$759,000.00 |
-$558,000.00 |
-$194,000.00 |
$0.00 |
-$10,000.00 |
-$30,000.00 |
-$31,000.00 |
-$20,000.00 |
-$23,907.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$115.24 M
|
$92.81 M
|
$84.72 M
|
$60.40 M
|
$47.83 M
|
$46.79 M
|
$26.43 M
|
$20.40 M
|
$17.78 M
|
$8.05 M
|
| General & Administrative
Expenses |
$50.57 M
|
$47.05 M
|
$46.54 M
|
$31.50 M
|
$19.65 M
|
$16.10 M
|
$9.65 M
|
$7.96 M
|
$6.09 M
|
$3.85 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$50.57 M
|
$47.05 M
|
$46.54 M
|
$31.50 M
|
$19.65 M
|
$16.10 M
|
$9.65 M
|
$7.96 M
|
$6.09 M
|
$3.85 M
|
| Other Expenses |
$0.00 |
$4.03 M |
$792,000.00 |
$2.27 M |
$4.34 M |
$2.44 M |
$643,000.00 |
$807,000.00 |
$1.24 M |
$2.00 M |
| Operating Expenses |
$165.80 M |
$139.87 M |
$131.26 M |
$91.90 M |
$67.48 M |
$62.88 M |
$36.08 M |
$28.37 M |
$23.87 M |
$10.90 M |
| Cost And Expenses |
$165.80 M |
$139.87 M |
$131.26 M |
$91.90 M |
$67.48 M |
$62.88 M |
$36.08 M |
$28.37 M |
$23.87 M |
$10.90 M |
| Interest Income |
$14.72 M |
$4.25 M |
$1.21 M |
$2.80 M |
$4.67 M |
$3.17 M |
$751,000.00 |
$499,000.00 |
$128,000.00 |
$0.00 |
| Interest Expense |
$1.55 M |
$229,000.00 |
$414,000.00 |
$578,000.00 |
$580,000.00 |
$970,000.00 |
$888,000.00 |
$577,000.00 |
$88,000.00 |
$5,877.00 |
| Depreciation &
Amortization |
$849,000.00
|
$759,000.00
|
$558,000.00
|
$194,000.00
|
$10,000.00
|
$10,000.00
|
$30,000.00
|
$31,000.00
|
$20,000.00
|
$3,000.00
|
| EBITDA |
-$164.96 M
|
-$139.11 M
|
-$129.71 M
|
-$91.71 M
|
-$67.48 M
|
-$62.87 M
|
-$36.05 M
|
-$28.34 M
|
-$23.85 M
|
-$11.80 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$13.17 M
|
$4.03 M
|
$792,000.00
|
$2.27 M
|
$4.44 M
|
$2.64 M
|
$943,000.00
|
$807,000.00
|
$972,000.00
|
$879,000.00
|
| Income Before Tax |
-$152.63 M |
-$135.84 M |
-$130.47 M |
-$89.63 M |
-$63.14 M |
-$60.45 M |
-$35.43 M |
-$27.56 M |
-$22.63 M |
-$11.01 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
$229,000.00 |
-$558,000.00 |
-$194,000.00 |
-$10.00 |
$3.41 M |
-$30,000.00 |
-$31,000.00 |
-$20,000.00 |
$268,877.00 |
| Net Income |
-$152.63 M |
-$136.07 M |
-$129.91 M |
-$89.43 M |
-$63.14 M |
-$60.45 M |
-$35.43 M |
-$27.56 M |
-$22.63 M |
-$11.01 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-2.08 |
-2.03 |
-1.96 |
-1.68 |
-1.51 |
-1.72 |
-1.52 |
-1.47 |
-2.28 |
-78.11 |
| EPS Diluted |
-2.08 |
-2.03 |
-1.96 |
-1.68 |
-1.51 |
-1.72 |
-1.52 |
-1.47 |
-2.28 |
-78.11 |
| Weighted Average Shares
Out |
$73.23 M
|
$66.99 M
|
$66.35 M
|
$53.08 M
|
$41.95 M
|
$35.19 M
|
$23.24 M
|
$18.70 M
|
$9.93 M
|
$141,000.00
|
| Weighted Average Shares
Out Diluted |
$73.23 M
|
$66.99 M
|
$66.35 M
|
$53.08 M
|
$41.95 M
|
$35.19 M
|
$23.24 M
|
$18.70 M
|
$9.93 M
|
$141,000.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
